AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $388,705 | +104.6% | 42,435 | +80.6% | 0.01% | -8.3% |
| Q4 2021 | $190,000 | +187.9% | 23,500 | +116.8% | 0.01% | +140.0% |
| Q2 2018 | $66,000 | -80.1% | 10,839 | -76.1% | 0.01% | -78.3% |
| Q1 2018 | $331,000 | +180.5% | 45,406 | +215.8% | 0.02% | +76.9% |
| Q4 2017 | $118,000 | -68.9% | 14,376 | -60.3% | 0.01% | -86.5% |
| Q3 2017 | $380,000 | +13.1% | 36,218 | +18.7% | 0.10% | +4.3% |
| Q2 2017 | $336,000 | +48.7% | 30,500 | +30.7% | 0.09% | +217.2% |
| Q1 2017 | $226,000 | – | 23,331 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |